stem cells int stem cells int sci stem cells international 1687 - 966x 1687 - 9678 hindawi publishing corporation 26989421 4773551 10.1155 / 2016 / 2732705 review article noncoding rnas in tumor epithelial - to - mesenchymal transition lin ching - wen 1 lin pei - ying 1 2 yang pan - chyr 1 3 * 1institute of biomedical sciences , academia sinica , taipei 11529 , taiwan 2national center of excellence for clinical trials and research center , department of medical research , national taiwan university hospital , taipei 10043 , taiwan 3department of internal medicine , national taiwan university hospital and college of medicine , national taiwan university , taipei 70101 , taiwan * pan - chyr yang : pcyang @ ntu.edu.tw academic editor : peter j. quesenberry 2016 16 2 2016 2016 2732705 4 12 2015 20 1 2016 copyright ( c ) 2016 ching - wen lin et al .
2016 this is an open access article distributed under the creative commons attribution license , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .
epithelial - derived tumor cells acquire the capacity for epithelial - to - mesenchymal transition ( emt ) , which enables them to invade adjacent tissues and / or metastasize to distant organs .
cancer metastasis is the main cause of cancer - related death .
molecular mechanisms involved in the switch from an epithelial phenotype to mesenchymal status are complicated and are controlled by a variety of signaling pathways .
recently , a set of noncoding rnas ( ncrnas ) , including mirnas and long noncoding rnas ( lncrnas ) , were found to modulate gene expressions at either transcriptional or posttranscriptional levels .
these ncrnas are involved in emt through their interplay with emt - related transcription factors ( emt - tfs ) and emt - associated signaling .
reciprocal regulatory interactions between lncrnas and mirnas further increase the complexity of the regulation of gene expression and protein translation .
in this review , we discuss recent findings regarding emt - regulating ncrnas and their associated signaling pathways involved in cancer progression .
1. introduction epithelial - to - mesenchymal transition ( emt ) is a critical step in both embryonic development and tumor metastasis .
emt is composed of serial phenotypic changes through which epithelial cells lose their apical - basal polarity and tight cellular adhesions , while acquiring protease - producing properties that increase cell motility [ 1 ] .
emt is a well - recognized process in tumor metastasis through which tumor cells seed and colonize areas distant from their primary sites .
the process of emt is sophisticatedly regulated and requires the acquisition of variable genetic alterations among tumor cells and their microenvironment [ 2 , 3 ] .
important cellular components of the tumor microenvironment ( tme ) include tumor - infiltrating immune cells , cancer - associated fibroblasts , and endothelial cells .
in addition , hypoxic conditions , which alter the composition of extracellular matrix ( ecm ) , cytokines , chemokines , and growth factors , are critical in the development of emt [ 4 , 5 ] .
among important tme - associated cytokines are members of the transforming growth factor - beta ( tgf - beta ) family , which paradoxically suppress tumor metastasis in early - stage cancers but drive the metastatic process in advanced disease .
tgf - beta signaling initiates emt by activating emt - inducing transcription factors ( emt - tfs ) , such as snail / slug , zinc - finger e - box - binding homeobox 1 / 2 ( zeb1 / 2 ) , basic helix - loop - helix ( bhlh ) protein , e47 , and twist , or by transcriptionally repressing epithelial - specific genes via members of the histone deacetylase ( hdac ) family [ 6 - 10 ] .
epithelial - specific genes , such as e - cadherin ( cdh1 ) , zona occludens 1 ( zo - 1 ) , and occludin ( ocln ) , are substantially downregulated at the transcriptional level during the emt process [ 11 - 13 ] .
notably , promoter regions of cdh1 and ocln genes contain emt - tf binding sites , termed e - boxes .
cdh1 and ocln are frequently downregulated in high - grade malignancies with poor clinical outcomes [ 14 - 17 ] , whereas mesenchymal markers , such as n - cadherin , vimentin , fibronectin , and alpha - smooth muscle actin ( alpha - sma ) , are upregulated [ 18 ] .
dynamic expression of these proteins results in alterations in cytoskeleton arrangements and cellular polarity , as well as changes in the ability of cells to degrade ecm .
recent cancer genomic studies have identified numerous rnas that do not encode proteins .
these noncoding rnas ( ncrnas ) , including snrnas , snornas , rrnas , trnas , pirnas , micrornas ( mirnas ) , and long noncoding rnas ( lncrnas ) , regulate biological functions through interactions between their specific structural domains and dna , rna , or proteins [ 19 ]. of these ncrnas , mirna and lncrnas have been found to serve as important gene expression regulators that fine - tune cell transcriptomes and adjust proteomes in response to extracellular stimulation [ 20 ] .
in addition , these noncoding rnas could be transported from primary site to another cell or distant organ through extracellular vesicles and alter the gene expression profile as well as their morphology and functions within the target sites [ 21 , 22 ] .
furthermore , mutations and dysregulations of mirnas and / or lncrnas are associated with a diverse array of human diseases , including cancer [ 23 - 27 ] .
in this review , we discuss recent findings on the roles of mirnas and lncrnas in regulating emt - tfs ( tables 1 and 2 ) .
we also discuss the multilayered regulatory circuits among mirnas , lncrnas , and protein - coding genes that are associated with cancer emt ( figure 1 ) .
2. emt - related signaling pathways and the tumor microenvironment the tme is a niche composed of various growth factors secreted by tumor cells or adjacent tissues , cytokines released by lymphoid cells , molecular components of the ecm , and intratumor hypoxia .
the expression of emt - tfs in cancer cells can be turned on in response to changes in the extracellular microenvironment .
signaling pathways , including those mediated by tgf - beta , bone morphogenetic protein ( bmp ) , wnt , notch , integrin , epidermal growth factor ( egf ) , fibroblast growth factor ( fgf ) , platelet - derived growth factor ( pdgf ) , and sonic hedgehog ( shh ) , are overactivated during carcinogenesis [ 28 , 29 ] .
in addition , tumor hypoxia is responsible for the expression of a subset of emt - tfs and activation of a category of emt - related signaling pathways .
here , we discuss several signaling pathways that participate in the initiation of cancer emt .
2.1 .
tgf - beta signaling pathway tgf - beta signaling is a core pathway that tightly controls the process of cell proliferation and emt during organ development , tissue fibrosis , and cancer progression [ 30 ] .
this signaling pathway is typically initiated by ligands belonging to the tgf - beta superfamily , which includes three isoforms of tgf - beta ( tgf - beta1 , tgf - beta2 , and tgf - beta3 ) and six isoforms of bmp ( bmp2 - 7 ) .
these ligands are expressed and secreted in different cellular contexts and in response to various stimuli [ 31 ] .
tgf - beta receptors are single - pass serine / threonine kinases that exist in different isoforms , including seven type i ( tgf - betari ) and five type ii ( tgf - betarii ) receptors that can form homo - or heterodimers .
combinatorial dimerization enables tgf - beta receptors to differentially activate intracellular signaling pathways that are broadly distinguished by their smad dependence or independence .
in response to phosphorylation of tgf - beta receptors , a smads ternary complex , composed of smad2 / 3 , r - smad and smad4 , forms and translocates from the cytoplasm to the nucleus [ 32 ] .
several emt - tfs , including members of the zeb family , snail / slug and twist , are transcriptionally upregulated in cancer cells by tgf - beta signaling through conserved response elements on the promoters of the corresponding genes [ 10 , 33 - 36 ] .
tgf - beta - smads was also shown to indirectly induce expression of emt - tfs by enhancing the expression of its downstream effector , high mobility group a2 ( hmga2 ) [ 37 , 38 ] .
activated tgf - beta signaling is sustained by an autocrine loop , which in turn reinforces the emt process [ 39 - 41 ] .
furthermore , snail and smad3 / 4 form a transcriptional repressor complex , which synergistically suppresses the expression of coxsackie and adenovirus receptor ( car ) , ocln , and cdh1 , and thus promotes emt [ 42 ] .
these results suggest the importance of tgf - beta signaling in cancer emt and its potential to serve as a therapeutic target .
2.2 .
wnt , notch , and mapk signaling pathways the wnt signaling pathway is an important regulator of emt - tf expression and the emt process .
wnt couples with the membrane protein frizzled and low - density lipoprotein receptor ( lrp ) , promoting translocation of beta - catenin from the cytoplasm to the nucleus .
in the nucleus , beta - catenin acts as a coactivator of tcf / lef1 ( t cell factor / lymphoid - enhancing factor - 1 ) and upregulates the transcription of snail1 / 2 and twist , which in turn repress e - cadherin [ 43 - 45 ] .
notch signaling is activated by cell - cell contact .
interactions between jag1 / 2 ( jagged - 1 / 2 ) , notch ligand , and notch receptors facilitate nuclear translocation of the notch intracellular domain ( nicd ) , which subsequently activates notch effector genes [ 46 ] .
notch signaling not only enhances snail transcription but also enhances snail1 / 2 function through upregulation of hypoxia - inducible factor 1alpha ( hif - 1alpha ) , thereby promoting tumor invasion and / or metastasis [ 47 , 48 ] .
additional pathways are also involved in cancer emt .
for example , hepatocyte growth factors ( hgfs ) and insulin - like growth factor - 1 ( igf - 1 ) upregulate expression of snail and zeb1 , respectively , through the mitogen - activated protein kinase ( mapk ) pathway [ 49 - 51 ] .
collectively , these observations suggest that emt - tf regulatory circuits are tightly controlled .
2.3 .
tumor microenvironment and hypoxia hypoxic microenvironments , defined as those with a po2 level less than 10 mmhg , trigger signaling cascades and immune responses that drive cancer progression [ 52 , 53 ] .
the hypoxic microenvironment contributes to the immune escape of tumors as well as tumor neovascularization and also promotes emt [ 4 ] .
tumor hypoxia - dependent signaling is predominantly mediated by hypoxia - inducible factors ( hifs ) - - important protein complexes that regulate tumor progression and metastasis [ 52 ] .
hifs , which consist of an unstable alpha - subunit and a stable beta - subunit [ 54 ] , bind to promoters of target genes that contain the hypoxia response element ( hre ) and promote the recruitment of transcriptional coactivators .
in hif - 1alpha - mediated canonical hypoxia signaling , expression levels of twist , snail , zeb1 , and e12 / e47 are upregulated [ 55 , 56 ] .
studies have shown that a hypoxic tme contributes to the stabilization of hif - 1alpha , which functions to activate tgf - beta signaling [ 57 , 58 ] .
tgf - beta , in turn , assists in the maintenance of hif - regulated vascular homeostasis and angiogenesis [ 59 , 60 ] .
the promoter region of vegf ( vascular endothelial growth factor ) , encoding a secretory factor involved in vasculogenesis and angiogenesis , harbors both hif - 1alpha and smad binding sites , suggesting the possibility that both hypoxia and tgf - beta signaling pathways regulate vegf expression [ 61 ] .
the positive feedback loop between hif - 1alpha and tgf - beta functions in the regulation of cancer emt and angiogenesis [ 62 ] .
the tme - associated hif - 1alpha - mediated hypoxia pathway also regulates cancer emt through notch signaling [ 48 , 63 , 64 ] .
it has been shown that interaction between nicd and hif - 1alpha increases the expression of snail and slug , which enhance cancer invasion and migration [ 48 , 65 ] .
in addition , a hypoxic tme augments the nuclear translocation of beta - catenin , which promotes activation of wnt signaling [ 66 ] .
collectively , these findings demonstrate that a hypoxic tme acts as a driving force for cancer emt , both directly , through stabilization of hifs , and indirectly , through paracrine / autocrine stimulation .
2.4 .
chemoresistance recent findings by in vivo mesenchymal lineage tracing showed that emt might not be essential for tumor metastasis , and interestingly the phenotype of emt in tumor cells was resistant to ctx ( cyclophosphamide ) and gemcitabine treatment [ 67 , 68 ] .
despite the fact that there may be other emt - inducing factors function to compensate for the genes that were manipulated in these studies , the discovery of emt tumors displayed chemoresistance may provide a new insight for developing novel therapy targeting tumor metastasis .
3. mirnas and emt mirnas are a group of small (~ 22 nucleotides ) ncrnas that mediate destabilization and translational suppression of downstream rnas at the posttranscriptional level .
the expression of mirnas can be ubiquitous or context - specific ( e.g. , during development or within certain tissues ) .
mirnas participate in a broad range of physiological functions .
therefore , mirna dysregulation may break the harmony of normal genetic activity and result in a diverse array of diseases , including cancer .
recent studies have revealed that more than 50 % of mirnas are dysregulated in human cancer .
moreover , prognostic and predictive mirna signatures have been reported in different types of cancer [ 125 - 127 ] .
mirnas serve both positive and negative roles in regulating cancer emt ( figure 1 and table 1 ) [ 128 ] .
the regulation of mirnas is complicated , as highlighted by the fact that some mirna targets can , in turn , regulate the expression of mirnas , forming regulatory loops .
two emt - related regulatory feedback loops formed by mirnas and emt - tfs will be discussed here : the mir - 200 family and zeb1 / 2 , and mir - 203 / mir - 34 and snail / slug .
3.1 .
reciprocal regulation between mirnas and emt - tfs : the mir - 200 family and zeb1 / 2 the mir - 200 family consists of five members , including mir - 200a / b / c , mir - 429 , and mir - 141 , all of which contain a similar seed sequence that targets a large common subset of genes [ 129 ] .
the mir - 200 family directly suppresses zeb1 / 2 translation , consequently upregulating the expression of e - cadherin and maintaining an epithelial cellular morphology [ 69 , 129 , 130 ] .
conversely , zeb1 has been shown to strongly promote tumorigenesis and cancer metastasis by inhibiting mir - 200c and mir - 203 transcription .
these data suggest that the mir - 200 family and zeb1 / 2 form a negative regulatory feedback loop [ 73 ] .
in pancreatic and breast cancer models , the mir - 200 family is reported to suppress notch - mediated zeb1 activation by directly targeting the notch coactivators maml2 and maml3 and the notch ligand , jag1 [ 70 ] .
in lung cancer , mir - 200 and gata binding protein 3 ( gata3 ) , a direct downstream target of notch involved in lung cancer metastasis , have been shown to mutually inhibit each other .
this inhibitory loop between mir - 200 and gata3 is perturbed by the notch ligand , jag2 [ 131 ] .
these results suggest that notch signaling broadens the spectrum of the mir - 200 / zeb1 negative feedback loop in regulating cancer emt and metastasis .
it has also been reported that mir - 200 is associated with the reverse emt process - - mesenchymal - epithelial transition ( met ) - - in prostate cancer .
mir - 200 and mir - 1 directly target the slug 3 ' - utr ( untranslated region ) , and slug in turn inhibits mir - 200 / mir - 1 expression [ 71 ] .
in addition , prolonged tgf - beta signaling increases mir - 200 promoter methylation and leads to mir - 200 suppression .
this suggests that the induction and maintenance of a mesenchymal state require autocrine tgf - beta signaling to sustain expression of emt - tfs and inhibition of the mir - 200 family [ 132 , 133 ] .
3.2 .
reciprocal regulation between mirnas and emt - tfs : mir - 203 / mir - 34 and snail / slug similar to the zeb / mir - 200 negative feedback loop , snail together with the mir - 34 family ( mir - 34a , mir - 34b , and mir - 34c ) and mir - 203 constitutes another negative feedback loop .
this negative feedback loop regulates epithelial plasticity [ 75 ] .
snail and mir - 34a / b / c control znf281 / zbp - 99 , a kruppel - type zinc - finger domain - containing transcription factor , acting as an integral component of an emt - related feed - forward loop [ 134 ] .
a negative feedback loop between mir - 203 and snail controls the dynamic transition between epithelial and mesenchymal phenotypes [ 135 , 136 ] .
mir - 203 has been shown to suppress slug expression in breast cancer cells , whereas tgf - beta - mediated slug activation reciprocally downregulates mir - 203 expression [ 136 , 137 ] .
a feedback loop also exists between p53 and mir34 .
the tumor - suppressor p53 upregulates the expression of mir - 34 , which subsequently suppresses emt .
mutated p53 proteins , in contrast , are unable to induce mir - 34 expression , thus shifting the equilibrium toward a mesenchymal phenotype [ 76 , 138 - 140 ] .
in addition , the p53 / mir - 34 axis suppresses wnt signaling , both in development and during cancer progression [ 138 ] .
these results illustrate how mirnas create networks that connect different emt - associated signaling pathways .
emt - related signaling not only upregulates emt - tfs but also suppresses mirnas ; this , in turn , breaks down mir - 200 / zeb and / or mir - 203 / snail / slug feedback loops and facilitates cancer emt ( figure 1 ) .
3.3 .
other emt - related mirnas several other mirnas are reported to be involved in emt ( table 1 ) .
for example , mir - 10b is transcriptionally upregulated by twist and induces tumor invasion and metastasis in breast cancers by targeting homeobox d10 ( hoxd10 ) [ 87 ] .
mir - 9 directly targets e - cadherin mrna , resulting in activation of beta - catenin signaling , which promotes emt and metastasis [ 78 ] .
mir - 9 upregulation has also been observed in c - myc - induced mouse mammary tumors [ 141 ] .
in addition , mir - 9 has been shown to downregulate leukemia inhibitory factor receptor ( lifr ) .
lifr suppresses breast cancer metastasis by activating the hippo kinase cascade , which in turn results in yap ( yes - associated protein ) inactivation [ 79 ] .
a recent study revealed that mir - 9 - 3p negatively regulates the expression of taz , a yap homolog [ 142 ] .
a recent study by our laboratory also showed that mir - 135b increases the levels of nuclear taz by directly suppressing multiple components of the hippo pathway , including lats2 ( large tumor - suppressor kinase 2 ) , mob1b ( mps one binder 1b ) , ndr2 ( nuclear - dbf2 - related 2 ) , and beta - trcp ( beta - transducin repeat - containing protein ) [ 80 ] .
notably , mir - 135b expression level , lats2 protein , and nuclear taz protein levels correlate with disease prognosis in non - small - cell lung cancer patients [ 80 ] .
furthermore , yap was found to physically interact with p72 , a rna helicase that plays roles in mirna processing [ 143 ] .
these results may suggest how the hippo pathway suppresses proliferation in response to contact inhibition .
3.4 .
mirnas involved in hypoxia - induced emt some mirnas are involved in hypoxia - induced emt .
expression of mir - 205 and mir - 124 , which regulate emt by targeting zeb1 / 2 and mmp2 ( matrix metallopeptidase 2 ) , respectively , is suppressed by hypoxia [ 69 , 144 , 145 ] .
hypoxia also downregulates the expression of mir - 34a , which acts as a suppressor of snail and zeb1 .
mir - 34a suppression results in upregulation of notch1 and jag1 , and activated notch signaling promotes emt [ 146 ] .
forced expression of mir - 34a under conditions of hypoxia not only reduces notch1 and jag1 expression but also abolishes snail expression , suggesting that the interplay between hypoxia and notch signaling is important in emt modulation ( figure 1 ) .
4. long noncoding rnas and emt lncrnas are rna transcripts longer than 200 nucleotides that do not encode proteins [ 147 ] .
the fantom project revealed that , in mammals , the number of lncrnas is at least four times that of protein - coding rnas [ 148 , 149 ] .
although the functions of lncrnas are largely unknown , accumulating evidence suggests that they are key regulators of a number of important biological processes , possibly exerting tissue - specific imprinting patterns and functioning in embryogenesis , development , lineage differentiation , tumorigenesis , and emt regulation [ 150 - 152 ] .
recent studies have shown that lncrna dysregulation is associated with cancer progression [ 153 ] .
lncrnas may interact with their nearby protein - coding genes , for example , tal1 , snail , slug , and the master regulator of hematopoiesis , scl / tal1 ( t cell acute lymphocytic leukemia 1 ) , as evidenced by the fact that depletion of certain lncrnas results in upregulation of these genes [ 154 ] .
in addition , some lncrnas encompass mirna binding sites .
these lncrnas function as cernas ( competing endogenous rna ) that antagonize mirnas .
lncrnas may positively or negatively regulate emt - associated proteins and mirnas , as discussed below ( figure 2 and table 2 ) .
4.1 .
lncrnas regulate emt through emt - tfs most lncrnas act as transcription inducers or form rna - protein complexes that promote expression of emt - associated genes at transcriptional or posttranslational levels [ 105 ] .
the lncrna , zeb1 - as1 , was found to be frequently upregulated in hepatocellular carcinoma ( hcc ) [ 103 ] .
zeb1 - as1 , whose transcription locus is close to zeb1 , increases zeb1 promoter activity through an unknown mechanism .
zeb1 , in turn , suppresses proteins that maintain the epithelial phenotype , such as e - cadherin , zo - 1 , and occludin [ 103 ] .
thus , targeting zeb1 - as1 may inhibit zeb1 - related emt .
expression of lncrna - atb , another lncrna that upregulates zeb1 / 2 expression and functions as a cerna , is enhanced by tgf - beta .
lncrna - atb promotes a metastatic cascade by competitively binding to members of the mir - 200 family , thereby attenuating the inhibitory function of mir - 200 on zeb1 / 2 .
at the same time , lncrna - atb upregulates interleukin - 11 ( il - 11 ) and activates il - 11 / stat3 ( signal transducer and activator of transcription 3 ) signaling , which enables cancer cell colonization [ 104 ] .
lncrna - hit , a hoxa transcript induced by tgf - beta , is a newly identified lncrna upregulated by tgf - beta that also mediates tgf - beta - induced emt [ 105 ] .
it has been found that lncrna - meg3 associates with a prc2 ( polycomb repressive complex 2 ) complex through interactions with ezh2 ( enhancer of zeste 2 polycomb repressive complex 2 subunit ) .
lncrna - meg3 is recruited to a ga - rich sequence in target genes , forming a rna - dna triplex structure that regulates expression of the tgf - beta receptor genes , tgfbr1 and tgfb2 , as well as smad2 [ 106 ] .
lncrna - hh , activated by twist at the transcriptional level , directly targets gas1 ( growth arrest - specific 1 ) and activates hedgehog signaling [ 103 ] .
the twist / lncrna - hh signaling cascade enhances the stemness property of cells , suggesting a connection between emt and stemness [ 107 ] .
4.2 .
lncrnas regulate emt through their interplay with mirnas emt is a tightly controlled physiological and pathological process .
not only proteins but also lncrnas and mirnas are involved in fine - tuning emt regulation .
lncrnas may serve as cernas , which act as molecular " sponges " to regulate the harmony of mirna pools and the biological signaling regulated by them .
interestingly , cernas absorb target mirnas without altering their total amount .
therefore , it is important to note that biological functions of mirnas are simply determined not only by their measured abundance but also by their interactions with lncrnas .
lncrnas are thus attractive therapeutic targets in mirna - mediated diseases .
three lncrnas - - h19 , malat1 , and hotair - - will be discussed in this section .
4.2.1 .
h19 h19 , which is highly expressed at the embryonic stage in mesodermal and endodermal tissues [ 155 ] , and insulin - like growth factor ii ( igf2 ) are reciprocally imprinted .
after the early gestation period , h19 is solely expressed from the maternal - inherited allele whereas igf2 is exclusively expressed from the paternal - inherited allele [ 156 , 157 ] .
loss of igf2 or h19 imprinting leads to igf2 upregulation and subsequent h19 promoter hypermethylation , a phenomenon commonly found in cancers [ 158 - 160 ] .
studies have suggested that h19 possesses tumor - suppressor functions and have implicated chromatin insulator protein ccctc - binding factor ( ctcf ) in methylating the promoter region of the h19 gene [ 161 , 162 ] .
how h19 functions in cells has grown clearer with the introduction mirnas [ 111 , 163 ] .
mir - 675 is an intergenic mirna embedded in the first exon of h19 and coexpressed with h19 .
h19 / mir - 675 negatively regulates insulin - like growth factor 1 receptor ( igf1r ) , nodal modulator 1 ( nomo1 ) , and twist proteins and suppresses tgf - beta1 / smads signaling [ 111 - 114 , 164 , 165 ] .
since tgf - beta / smad signaling is a well - known emt pathway , it is possible that h19 / mir - 675 plays a role in emt regulation .
on the other hand , a cancer - promoting role of h19 has been suggested in colorectal and gastric cancers [ 115 , 166 ] .
in colorectal cancer , overexpressed h19 serves as a cerna that antagonizes mir - 138 and mir - 200a , leading to derepression of their endogenous targets , vimentin , zeb1 , and zeb2 [ 115 ] .
in addition , h19 was found to harbor several binding sites for let - 7 family mirnas and act as a sponge that negatively regulates their activity [ 167 ] .
notably , expression of let - 7 mirnas , which inhibit emt by suppressing hmga2 , is frequently downregulated in cancers with a mesenchymal phenotype .
thus , h19 may exert an emt - promoting function through its role as a mir - 200 and let - 7 family sponge [ 116 , 117 ] .
these results suggest that the dual roles of h19 in cancer emt regulation are deciphered by cellular context , in which different sets of mirnas are involved in disease pathogenesis .
4.2.2 .
malat1 malat1 ( metastasis associated in lung adenocarcinoma transcript 1 ) has been reported to be a prognostic marker in several cancers , including lung , breast , pancreas , liver , colon , uterus , cervix , and prostate cancers [ 118 ] .
in bladder cancer , tgf - beta1 induces malat1 expression , whereas silencing of endogenous malat1 and its binding partner , suz12 , suppresses tgf - beta1 - induced emt [ 119 ] .
in renal cancer , reciprocal crosstalk among malat1 , mir - 205 , and ezh2 suppresses the expression of e - cadherin and enhances wnt signaling activity , thereby promoting cancer metastasis [ 120 ] .
ezh2 and suz12 are subunits of prc2 , which is responsible for the repressive histone 3 lysine 27 trimethylation ( h3k27me3 ) chromatin modification .
previous studies have suggested that malat1 might be associated with the prc2 complex and promote cancer emt .
4.2.3 .
hotair hotair ( hox transcript antisense intergenic rna ) epigenetically regulates its target sequences by recruiting prc2 , which in turn results in gene silencing [ 168 , 169 ] .
hotair upregulation was found to be a prognostic indicator of poor outcome in various types of cancers [ 121 , 122 ] .
in addition , hotair was shown to be required for tgf - beta - mediated emt in colon cancer [ 170 ] .
hotair epigenetically silences mir - 34 transcription , resulting in augmentation of c - met and snail expression [ 123 ] .
it was also found that mir - 141 , an emt suppressor , decreases the expression of hotair through complementary binding and thereby inhibits its oncogenic functions [ 124 ] .
mir - 141 negatively regulates hotair target genes , including snail , the nonreceptor tyrosine kinase abl2 , and pcdh10 ( protocadherin 10 ) .
in addition , the expression levels of mir - 141 and hotair were found to be inversely correlated in renal cancer cells [ 124 ] .
these results suggest that crosstalk between hotair and mirnas play important roles in cancer emt regulation .
5. conclusion emt is recognized as the first step of cancer metastasis - - the main cause of cancer mortality .
cancer emt is a tightly controlled pathological process .
multilayered regulatory elements , including proteins , mirnas , and lncrnas , are involved in the complex emt regulatory networks through rna - protein , rna - mirnas , and rna - dna interactions at pretranscriptional , posttranscriptional , and posttranslational levels .
ncrnas modulate epithelial plasticity by targeting different signaling pathways , emt - tfs , and / or emt - associated proteins .
several important reciprocal feedback loops , composed of ncrnas and emt - tfs , are involved in establishing flexible control over emt and met .
therefore , peeling back the mysteries surrounding ncrnas in emt regulation will be important in furthering advances in cancer therapy strategies ( figure 3 ) .
acknowledgments the authors apologize to their colleagues whose work could not be cited owing to space limitations .
the work in the author 's laboratory was supported by ministry of science and technology , taiwan ( most 103 - 2321 - b - 002 - 022 ; most 104 - 2314 - b - 002 - 228 - my3 ) , and national taiwan university ( ntu103r7601 - 2 ; ntu104r7601 - 2 ) .
conflict of interests the authors declare that there is no conflict of interests regarding the publication of this paper .
1 thiery j. p. acloque h. huang r. y. j. nieto m. a. epithelial - mesenchymal transitions in development and disease cell 2009 139 5 871 890 10.1016 / j.cell.2009.11.007 2 - s2.0 - 70450198396 19945376 2 nieto m. a. epithelial plasticity : a common theme in embryonic and cancer cells science 2013 342 6159 1234850 10.1126 / science.1234850 2 - s2.0 - 84887273608 3 de craene b. berx g. regulatory networks defining emt during cancer initiation and progression nature reviews cancer 2013 13 2 97 110 10.1038 / nrc3447 2 - s2.0 - 84873050284 23344542 4 philip b. ito k. moreno - sanchez r. ralph s. j. hif expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression carcinogenesis 2013 34 8 1699 1707 10.1093 / carcin / bgt209 2 - s2.0 - 84881539307 23740838 5 taddei m. l. giannoni e. comito g. chiarugi p. microenvironment and tumor cell plasticity : an easy way out cancer letters 2013 341 1 80 96 10.1016 / j.canlet.2013.01.042 2 - s2.0 - 84887188959 23376253 6 yang j. mani s. a. donaher j. l. twist , a master regulator of morphogenesis , plays an essential role in tumor metastasis cell 2004 117 7 927 939 10.1016 / j.cell.2004.06.006 2 - s2.0 - 2942707848 15210113 7 chen z .
- f. behringer r. r. twist is required in head mesenchyme for cranial neural tube morphogenesis genes & development 1995 9 6 686 699 10.1101 / gad.9.6.686 2 - s2.0 - 0028933142 7729687 8 cano a. perez - moreno m. a. rodrigo i. the transcription factor snail controls epithelial - mesenchymal transitions by repressing e - cadherin expression nature cell biology 2000 2 2 76 83 10.1038 / 35000025 2 - s2.0 - 0033784843 10655586 9 nieto m. a. the snail superfamily of zinc - finger transcription factors nature reviews molecular cell biology 2002 3 3 155 166 10.1038 / nrm757 2 - s2.0 - 0036513626 11994736 10 peinado h. olmeda d. cano a. snail , zeb and bhlh factors in tumour progression : an alliance against the epithelial phenotype ?
nature reviews cancer 2007 7 6 415 428 10.1038 / nrc2131 2 - s2.0 - 34249289041 17508028 11 ikenouchi j. matsuda m. furuse m. tsukita s. regulation of tight junctions during the epithelium - mesenchyme transition : direct repression of the gene expression of claudins / occludin by snail journal of cell science 2003 116 10 1959 1967 10.1242 / jcs.00389 2 - s2.0 - 0038106228 12668723 12 kemler r. from cadherins to catenins : cytoplasmic protein interactions and regulation of cell adhesion trends in genetics 1993 9 9 317 321 10.1016 / 0168 - 9525 ( 93 ) 90250 - l 2 - s2.0 - 0027185632 8236461 13 puisieux a. brabletz t. caramel j. oncogenic roles of emt - inducing transcription factors nature cell biology 2014 16 6 488 494 10.1038 / ncb2976 2 - s2.0 - 84901787644 24875735 14 huber g. f. zullig l. soltermann a. down regulation of e - cadherin ( ecad ) - - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx bmc cancer 2011 11 217 211 218 10.1186 / 1471 - 2407 - 11 - 217 2 - s2.0 - 79957864140 21624110 15 birchmeier w. behrens j. cadherin expression in carcinomas : role in the formation of cell junctions and the prevention of invasiveness biochimica et biophysica acta ( bba ) - - reviews on cancer 1994 1198 1 11 26 10.1016 / 0304 - 419x ( 94 ) 90003 - 5 2 - s2.0 - 0028245813 8199193 16 tsukita s. yamazaki y. katsuno t. tamura a. tsukita s. tight junction - based epithelial microenvironment and cell proliferation oncogene 2008 27 55 6930 6938 10.1038 / onc.2008.344 2 - s2.0 - 56749184887 19029935 17 chao y .
- c. pan s .
- h. yang s .
- c. claudin - 1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma american journal of respiratory and critical care medicine 2009 179 2 123 133 10.1164 / rccm.200803 - 456oc 2 - s2.0 - 58449129163 18787218 18 kalluri r. weinberg r. a. the basics of epithelial - mesenchymal transition the journal of clinical investigation 2009 119 6 1420 1428 10.1172 / jci39104 2 - s2.0 - 67650999875 19487818 19 cech t. r. steitz j. a. the noncoding rna revolution - - trashing old rules to forge new ones cell 2014 157 1 77 94 10.1016 / j.cell.2014.03.008 2 - s2.0 - 84897128298 24679528 20 kapranov p. cheng j. dike s. rna maps reveal new rna classes and a possible function for pervasive transcription science 2007 316 5830 1484 1488 10.1126 / science.1138341 2 - s2.0 - 34250160256 17510325 21 collino f. bruno s. incarnato d. aki recovery induced by mesenchymal stromal cell - derived extracellular vesicles carrying micrornas journal of the american society of nephrology 2015 26 10 2349 2360 10.1681 / asn.2014070710 25901032 22 camussi g. quesenberry p. j. perspectives on the potential therapeutic uses of vesicles exosomes and microvesicles 2013 1 6 10.5772 / 57393 23 diederichs s. the four dimensions of noncoding rna conservation trends in genetics 2014 30 4 121 123 10.1016 / j.tig.2014.01.004 2 - s2.0 - 84897030160 24613441 24 braconi c. kogure t. valeri n. microrna - 29 can regulate expression of the long non - coding rna gene meg3 in hepatocellular cancer oncogene 2011 30 47 4750 4756 10.1038 / onc.2011.193 2 - s2.0 - 81855183267 21625215 25 ergun s. oztuzcu s. oncocers : cerna - mediated cross - talk by sponging mirnas in oncogenic pathways tumor biology 2015 36 5 3129 3136 10.1007 / s13277 - 015 - 3346 - x 25809705 26 cui m. xiao z. wang y. long noncoding rna hulc modulates abnormal lipid metabolism in hepatoma cells through an mir - 9 - mediated rxra signaling pathway cancer research 2015 75 5 846 857 10.1158 / 0008 - 5472.can - 14 - 1192 25592151 27 zhang h. cai k. wang j. mir - 7 , inhibited indirectly by lincrna hotair , directly inhibits setdb1 and reverses the emt of breast cancer stem cells by downregulating the stat3 pathway stem cells 2014 32 11 2858 2868 10.1002 / stem.1795 2 - s2.0 - 84907895333 25070049 28 gonzalez d. m. medici d. signaling mechanisms of the epithelial - mesenchymal transition science signaling 2014 7 344 , article re8 10.1126 / scisignal.2005189 2 - s2.0 - 84907501988 29 timmerman l. a. grego - bessa j. raya a. notch promotes epithelial - mesenchymal transition during cardiac development and oncogenic transformation genes & development 2004 18 1 99 115 10.1101 / gad.276304 2 - s2.0 - 9144246932 14701881 30 tirado - rodriguez b. ortega e. segura - medina p. huerta - yepez s. tgf - beta : an important mediator of allergic disease and a molecule with dual activity in cancer development journal of immunology research 2014 2014 15 318481 10.1155 / 2014 / 318481 2 - s2.0 - 84903625121 31 akhurst r. j. derynck r. tgf - beta signaling in cancer - - a double - edged sword trends in cell biology 2001 11 11 s44 s51 10.1016 / s0962 - 8924 ( 01 ) 02130 - 4 2 - s2.0 - 0035501062 11684442 32 derynck r. zhang y. feng x .
- h. smads : transcriptional activators of tgf - beta responses cell 1998 95 6 737 740 10.1016 / s0092 - 8674 ( 00 ) 81696 - 7 2 - s2.0 - 0032442852 9865691 33 peinado h. quintanilla m. cano a. transforming growth factor beta - 1 induces snail transcription factor in epithelial cell lines : mechanisms for epithelial mesenchymal transitions the journal of biological chemistry 2003 278 23 21113 21123 10.1074 / jbc.m211304200 2 - s2.0 - 0038756636 12665527 34 slabakova e. pernicova z. slavickova e. starsichova a. kozubik a. soucek k. tgf - beta1 - induced emt of non - transformed prostate hyperplasia cells is characterized by early induction of snai2 / slug prostate 2011 71 12 1332 1343 10.1002 / pros.21350 2 - s2.0 - 79960705270 21321977 35 wu y .
- y. peck k. chang y .
- l .
scube3 is an endogenous tgf - beta receptor ligand and regulates the epithelial - mesenchymal transition in lung cancer oncogene 2011 30 34 3682 3693 10.1038 / onc.2011.85 2 - s2.0 - 80052062312 21441952 36 zavadil j. bottinger e. p. tgf - beta and epithelial - to - mesenchymal transitions oncogene 2005 24 37 5764 5774 10.1038 / sj.onc.1208927 2 - s2.0 - 24644487312 16123809 37 thuault s. valcourt u. petersen m. manfioletti g. heldin c .
- h. moustakas a. transforming growth factor - beta employs hmga2 to elicit epithelial - mesenchymal transition journal of cell biology 2006 174 2 175 183 10.1083 / jcb.200512110 2 - s2.0 - 33746034613 16831886 38 zhang h. zhang h. liu l .
klf8 involves in tgf - beta - induced emt and promotes invasion and migration in gastric cancer cells journal of cancer research and clinical oncology 2013 139 6 1033 1042 10.1007 / s00432 - 012 - 1363 - 3 2 - s2.0 - 84878343416 23504025 39 wu j. ru n .
- y. zhang y .
hab18g / cd147 promotes epithelial - mesenchymal transition through tgf - beta signaling and is transcriptionally regulated by slug oncogene 2011 30 43 4410 4427 10.1038 / onc.2011.149 2 - s2.0 - 80055051887 21532623 40 dhasarathy a. phadke d. mav d. shah r. r. wade p. a. the transcription factors snail and slug activate the transforming growth factor - beta signaling pathway in breast cancer plos one 2011 6 10 e26514 10.1371 / journal.pone.0026514 2 - s2.0 - 80054784515 41 zhang j. tian x .
- j. zhang h. tgf - beta - induced epithelial - to - mesenchymal transition proceeds through stepwise activation of multiple feedback loops science signaling 2014 7 345 , article ra91 10.1126 / scisignal.2005304 2 - s2.0 - 84907877191 42 vincent t. neve e. p. a. johnson j. r. a snail1 - smad3 / 4 transcriptional repressor complex promotes tgf - beta mediated epithelial - mesenchymal transition nature cell biology 2009 11 8 943 950 10.1038 / ncb1905 2 - s2.0 - 68249092353 19597490 43 conacci - sorrell m. simcha i. ben - yedidia t. blechman j. savagner p. ben - ze'ev a. autoregulation of e - cadherin expression by cadherin - cadherin interactions : the roles of beta - catenin signaling , slug , and mapk the journal of cell biology 2003 163 4 847 857 10.1083 / jcb.200308162 2 - s2.0 - 0345599013 14623871 44 yook j. i. li x .
- y. ota i. a wnt - axin2 - gsk3beta cascade regulates snail1 activity in breast cancer cells nature cell biology 2006 8 12 1398 1406 10.1038 / ncb1508 2 - s2.0 - 33751514601 17072303 45 howe l. r. watanabe o. leonard j. brown a. m. c. twist is up - regulated in response to wnt1 and inhibits mouse mammary cell differentiation cancer research 2003 63 8 1906 1913 2 - s2.0 - 0345700653 12702582 46 kopan r. notch : a membrane - bound transcription factor journal of cell science 2002 115 6 1095 1097 2 - s2.0 - 0037087506 11884509 47 leong k. g. niessen k. kulic i .
jagged1 - mediated notch activation induces epithelial - to - mesenchymal transition through slug - induced repression of e - cadherin the journal of experimental medicine 2007 204 12 2935 2948 10.1084 / jem.20071082 2 - s2.0 - 36549010842 17984306 48 sahlgren c. gustafsson m. v. jin s. poellinger l. lendahl u. notch signaling mediates hypoxia - induced tumor cell migration and invasion proceedings of the national academy of sciences of the united states of america 2008 105 17 6392 6397 10.1073 / pnas.0802047105 2 - s2.0 - 44049090235 18427106 49 nagai t. arao t. furuta k. sorafenib inhibits the hepatocyte growth factor - mediated epithelial mesenchymal transition in hepatocellular carcinoma molecular cancer therapeutics 2011 10 1 169 177 10.1158 / 1535 - 7163.mct - 10 - 0544 2 - s2.0 - 78751523982 21220499 50 graham t. r. zhau h. e. odero - marah v. a. insulin - like growth factor - i - dependent up - regulation of zeb1 drives epithelial - to - mesenchymal transition in human prostate cancer cells cancer research 2008 68 7 2479 2488 10.1158 / 0008 - 5472.can - 07 - 2559 2 - s2.0 - 42049092980 18381457 51 grotegut s. von schweinitz d. christofori g. lehembre f. hepatocyte growth factor induces cell scattering through mapk / egr - 1 - mediated upregulation of snail the embo journal 2006 25 15 3534 3545 10.1038 / sj.emboj.7601213 2 - s2.0 - 33747625686 16858414 52 tsai y .
- p. wu k .
- j. hypoxia - regulated target genes implicated in tumor metastasis journal of biomedical science 2012 19 , article 102 10.1186 / 1423 - 0127 - 19 - 102 2 - s2.0 - 84870941135 53 gilkes d. m. semenza g. l. wirtz d. hypoxia and the extracellular matrix : drivers of tumour metastasis nature reviews cancer 2014 14 6 430 439 10.1038 / nrc3726 2 - s2.0 - 84901594345 24827502 54 kaelin w. g. jr. ratcliffe p. j. oxygen sensing by metazoans : the central role of the hif hydroxylase pathway molecular cell 2008 30 4 393 402 10.1016 / j.molcel.2008.04.009 2 - s2.0 - 43649093915 18498744 55 yang m .
- h. wu m .
- z. chiou s .
- h. direct regulation of twist by hif - 1alpha promotes metastasis nature cell biology 2008 10 3 295 305 10.1038 / ncb1691 2 - s2.0 - 40249113328 18297062 56 lundgren k. nordenskjold b. landberg g. hypoxia , snail and incomplete epithelial - mesenchymal transition in breast cancer british journal of cancer 2009 101 10 1769 1781 10.1038 / sj.bjc.6605369 2 - s2.0 - 70449527638 19844232 57 orphanides c. fine l. g. norman j. t. hypoxia stimulates proximal tubular cell matrix production via a tgf - beta1 - independent mechanism kidney international 1997 52 3 637 647 10.1038 / ki.1997.377 2 - s2.0 - 0030866613 9291182 58 toomey d. condron c. di wu q. tgf - beta1 is elevated in breast cancer tissue and regulates nitric oxide production from a number of cellular sources during hypoxia re - oxygenation injury british journal of biomedical science 2001 58 3 177 183 2 - s2.0 - 0034741083 11575741 59 harada h. itasaka s. zhu y. treatment regimen determines whether an hif - 1 inhibitor enhances or inhibits the effect of radiation therapy british journal of cancer 2009 100 5 747 757 10.1038 / sj.bjc.6604939 2 - s2.0 - 61749090849 19223896 60 furuta c. miyamoto t. takagi t. transforming growth factor - beta signaling enhancement by long - term exposure to hypoxia in a tumor microenvironment composed of lewis lung carcinoma cells cancer science 2015 106 11 1524 1533 26296946 61 sanchez - elsner t. botella l. m. velasco b. corbi a. attisano l. bernabeu c. synergistic cooperation between hypoxia and transforming growth factor - beta pathways on human vascular endothelial growth factor gene expression the journal of biological chemistry 2001 276 42 38527 38535 10.1074 / jbc.m104536200 2 - s2.0 - 0035914297 11486006 62 lu x. kang y. hypoxia and hypoxia - inducible factors : master regulators of metastasis clinical cancer research 2010 16 24 5928 5935 10.1158 / 1078 - 0432.ccr - 10 - 1360 2 - s2.0 - 78650373860 20962028 63 chen y. de marco m. a. graziani i. oxygen concentration determines the biological effects of notch - 1 signaling in adenocarcinoma of the lung cancer research 2007 67 17 7954 7959 10.1158 / 0008 - 5472.can - 07 - 1229 2 - s2.0 - 34548599785 17804701 64 zheng x. linke s. dias j. m. interaction with factor inhibiting hif - 1 defines an additional mode of cross - coupling between the notch and hypoxia signaling pathways proceedings of the national academy of sciences of the united states of america 2008 105 9 3368 3373 10.1073 / pnas.0711591105 2 - s2.0 - 42149117769 18299578 65 chen j. imanaka n. chen j. griffin j. d. hypoxia potentiates notch signaling in breast cancer leading to decreased e - cadherin expression and increased cell migration and invasion british journal of cancer 2010 102 2 351 360 10.1038 / sj.bjc.6605486 2 - s2.0 - 75549083984 20010940 66 cannito s. novo e. compagnone a. redox mechanisms switch on hypoxia - dependent epithelial - mesenchymal transition in cancer cells carcinogenesis 2008 29 12 2267 2278 10.1093 / carcin / bgn216 2 - s2.0 - 57349164238 18791199 67 zheng x. carstens j. l. kim j. epithelial - to - mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer nature 2015 527 7579 525 530 10.1038 / nature16064 26560028 68 fischer k. r. durrans a. lee s. epithelial - to - mesenchymal transition is not required for lung metastasis but contributes to chemoresistance nature 2015 527 7579 472 476 10.1038 / nature15748 26560033 69 gregory p. a. bert a. g. paterson e. l. the mir - 200 family and mir - 205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1 nature cell biology 2008 10 5 593 601 10.1038 / ncb1722 2 - s2.0 - 43049103824 18376396 70 brabletz s. bajdak k. meidhof s. the zeb1 / mir - 200 feedback loop controls notch signalling in cancer cells the embo journal 2011 30 4 770 782 10.1038 / emboj.2010.349 2 - s2.0 - 79951813950 21224848 71 liu y .
- n. yin j. j. abou - kheir w. mir - 1 and mir - 200 inhibit emt via slug - dependent and tumorigenesis via slug - independent mechanisms oncogene 2013 32 3 296 306 10.1038 / onc.2012.58 2 - s2.0 - 84872608167 22370643 72 song s. j. poliseno l. song m. s. microrna - antagonism regulates breast cancer stemness and metastasis via tet - family - dependent chromatin remodeling cell 2013 154 2 311 324 10.1016 / j.cell.2013.06.026 2 - s2.0 - 84880570961 23830207 73 wellner u. schubert j. burk u. c. the emt - activator zeb1 promotes tumorigenicity by repressing stemness - inhibiting micrornas nature cell biology 2009 11 12 1487 1495 10.1038 / ncb1998 2 - s2.0 - 73049110243 19935649 74 qu y. li w .
- c. hellem m. r. mir - 182 and mir - 203 induce mesenchymal to epithelial transition and self - sufficiency of growth signals via repressing snai2 in prostate cells international journal of cancer 2013 133 3 544 555 10.1002 / ijc.28056 2 - s2.0 - 84878016403 23354685 75 kim n. h. kim h. s. li x .
- y. a p53 / mirna - 34 axis regulates snail1 - dependent cancer cell epithelial - mesenchymal transition the journal of cell biology 2011 195 3 417 433 10.1083 / jcb.201103097 2 - s2.0 - 84855729906 22024162 76 he l. he x. lim l. p. a microrna component of the p53 tumour suppressor network nature 2007 447 7148 1130 1134 10.1038 / nature05939 2 - s2.0 - 34250851115 17554337 77 nalls d. tang s .
- n. rodova m. srivastava r. k. shankar s. targeting epigenetic regulation of mir - 34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells plos one 2011 6 8 e24099 10.1371 / journal.pone.0024099 2 - s2.0 - 80052316514 78 martello g. rosato a. ferrari f. a microrna targeting dicer for metastasis control cell 2010 141 7 1195 1207 10.1016 / j.cell.2010.05.017 2 - s2.0 - 77953898940 20603000 79 chen d. sun y. wei y. lifr is a breast cancer metastasis suppressor upstream of the hippo - yap pathway and a prognostic marker nature medicine 2012 18 10 1511 1517 10.1038 / nm.2940 2 - s2.0 - 84870261155 80 lin c .
- w. chang y .
- l. chang y .
- c. microrna - 135b promotes lung cancer metastasis by regulating multiple targets in the hippo pathway and lzts1 nature communications 2013 4 , article 1877 10.1038 / ncomms2876 2 - s2.0 - 84878703345 81 zhang l. sun z .
- j. bian y. kulkarni a. b. microrna - 135b acts as a tumor promoter by targeting the hypoxia - inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma cancer letters 2013 331 2 230 238 10.1016 / j.canlet.2013.01.003 2 - s2.0 - 84875373097 23340180 82 nagel r. le sage c. diosdado b. regulation of the adenomatous polyposis coli gene by the mir - 135 family in colorectal cancer cancer research 2008 68 14 5795 5802 10.1158 / 0008 - 5472.can - 08 - 0951 2 - s2.0 - 48649099908 18632633 83 huang x. ding l. bennewith k. l. hypoxia - inducible mir - 210 regulates normoxic gene expression involved in tumor initiation molecular cell 2009 35 6 856 867 10.1016 / j.molcel.2009.09.006 2 - s2.0 - 70349168446 19782034 84 chan s. y. loscalzo j. microrna - 210 : a unique and pleiotropic hypoxamir cell cycle 2010 9 6 1072 1083 10.4161 / cc.9.6.11006 2 - s2.0 - 77953483108 20237418 85 volinia s. galasso m. sana m. e. breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microrna proceedings of the national academy of sciences of the united states of america 2012 109 8 3024 3029 10.1073 / pnas.1200010109 2 - s2.0 - 84857399748 22315424 86 chen h .
- y. lin y .
- m. chung h .
- c. mir - 103 / 107 promote metastasis of colorectal cancer by targeting the metastasis suppressors dapk and klf4 cancer research 2012 72 14 3631 3641 10.1158 / 0008 - 5472.can - 12 - 0667 2 - s2.0 - 84863891322 22593189 87 ma l. teruya - feldstein j. weinberg r. a. tumour invasion and metastasis initiated by microrna - 10b in breast cancer nature 2007 449 7163 682 688 10.1038 / nature06174 2 - s2.0 - 35148886434 17898713 88 toiyama y. takahashi m. hur k. serum mir - 21 as a diagnostic and prognostic biomarker in colorectal cancer journal of the national cancer institute 2013 105 12 849 859 10.1093 / jnci / djt101 2 - s2.0 - 84883030137 23704278 89 wang y. li j. tong l. the prognostic value of mir - 21 and mir - 155 in non - small - cell lung cancer : a meta - analysis japanese journal of clinical oncology 2013 43 8 813 820 10.1093 / jjco / hyt084 2 - s2.0 - 84881106967 23817461 90 davis b. n. hilyard a. c. lagna g. hata a. smad proteins control drosha - mediated microrna maturation nature 2008 454 7200 56 61 10.1038 / nature07086 2 - s2.0 - 46449128469 18548003 91 bornachea o. santos m. martinez - cruz a. b. emt and induction of mir - 21 mediate metastasis development in trp53 - deficient tumours scientific reports 2012 2 , article 434 10.1038 / srep00434 2 - s2.0 - 84861701969 92 huang t .
- h. wu f. loeb g. b. up - regulation of mir - 21 by her2 / neu signaling promotes cell invasion the journal of biological chemistry 2009 284 27 18515 18524 10.1074 / jbc.m109.006676 2 - s2.0 - 67650538055 19419954 93 dang t. t. esparza m. a. maine e. a. westcott j. m. pearson g. w. deltanp63alpha promotes breast cancer cell motility through the selective activation of components of the epithelial - to - mesenchymal transition program cancer research 2015 75 3925 3935 26292362 94 chao c .
- h. chang c .
- c. wu m .
- j. microrna - 205 signaling regulates mammary stem cell fate and tumorigenesis the journal of clinical investigation 2014 124 7 3093 3106 10.1172 / jci73351 2 - s2.0 - 84903767171 24911147 95 zhang h. hao y. yang j. genome - wide functional screening of mir - 23b as a pleiotropic modulator suppressing cancer metastasis nature communications 2011 2 1 , article 554 10.1038 / ncomms1555 2 - s2.0 - 82555193281 96 majid s. dar a. a. saini s. mir - 23b represses proto - oncogene src kinase and functions as methylation - silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer cancer research 2012 72 24 6435 6446 10.1158 / 0008 - 5472.can - 12 - 2181 2 - s2.0 - 84871222985 23074286 97 majid s. dar a. a. saini s. microrna - 23b functions as a tumor suppressor by regulating zeb1 in bladder cancer plos one 2013 8 7 e67686 10.1371 / journal.pone.0067686 2 - s2.0 - 84879753216 98 yeh y .
- m. chuang c .
- m. chao k .
- c. wang l .
- h. microrna - 138 suppresses ovarian cancer cell invasion and metastasis by targeting sox4 and hif - 1alpha international journal of cancer 2013 133 4 867 878 10.1002 / ijc.28086 2 - s2.0 - 84878830070 23389731 99 liu x. jiang l. wang a. yu j. shi f. zhou x. microrna - 138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines cancer letters 2009 286 2 217 222 10.1016 / j.canlet.2009.05.030 2 - s2.0 - 70449712813 19540661 100 liu x. wang c. chen z. microrna - 138 suppresses epithelial - mesenchymal transition in squamous cell carcinoma cell lines biochemical journal 2011 440 1 23 31 10.1042 / bj20111006 2 - s2.0 - 80054884390 21770894 101 zhao x. dou w. he l. microrna - 7 functions as an anti - metastatic microrna in gastric cancer by targeting insulin - like growth factor - 1 receptor oncogene 2013 32 11 1363 1372 10.1038 / onc.2012.156 2 - s2.0 - 84875222626 22614005 102 akalay i. tan t. z. kumar p. targeting wnt1 - inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of klf - 4 and mir - 7 expression oncogene 2015 34 17 2261 2271 24931170 103 li t. xie j. shen c. upregulation of long noncoding rna zeb1 - as1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma oncogene 2015 10.1038 / onc.2015.223 104 yuan j .
- h. yang f. wang f. a long noncoding rna activated by tgf - beta promotes the invasion - metastasis cascade in hepatocellular carcinoma cancer cell 2014 25 5 666 681 10.1016 / j.ccr.2014.03.010 2 - s2.0 - 84900316922 24768205 105 richards e. j. zhang g. li z. p. long non - coding rnas ( lncrna ) regulated by transforming growth factor ( tgf ) beta : lncrna - hit - mediated tgfbeta - induced epithelial to mesenchymal transition in mammary epithelia the journal of biological chemistry 2015 290 11 6857 6867 25605728 106 mondal t. subhash s. vaid r .
meg3 long noncoding rna regulates the tgf - beta pathway genes through formation of rna - dna triplex structures nature communications 2015 6 , article 7743 10.1038 / ncomms8743 107 zhou m. hou y. yang g. lncrna - hh strengthen cancer stem cells generation in twist - positive breast cancer via activation of hedgehog signaling pathway stem cells 2016 34 1 55 66 10.1002 / stem.2219 26418365 108 wang y. he l. du y. the long noncoding rna lnctcf7 promotes self - renewal of human liver cancer stem cells through activation of wnt signaling cell stem cell 2015 16 4 413 425 10.1016 / j.stem.2015.03.003 25842979 109 wu j. zhang j. shen b. long noncoding rna lnctcf7 , induced by il - 6 / stat3 transactivation , promotes hepatocellular carcinoma aggressiveness through epithelial - mesenchymal transition journal of experimental & clinical cancer research 2015 34 1 , article 116 10.1186 / s13046 - 015 - 0229 - 3 110 gumireddy k. li a. yan j. identification of a long non - coding rna - associated rnp complex regulating metastasis at the translational step the embo journal 2013 32 20 2672 2684 10.1038 / emboj.2013.188 2 - s2.0 - 84885852048 23974796 111 smits g. mungall a. j. griffiths - jones s. conservation of the h19 noncoding rna and h19 - igf2 imprinting mechanism in therians nature genetics 2008 40 8 971 976 10.1038 / ng.168 2 - s2.0 - 48249141249 18587395 112 keniry a. oxley d. monnier p. the h19 lincrna is a developmental reservoir of mir - 675 that suppresses growth and igf1r nature cell biology 2012 14 7 659 665 10.1038 / ncb2521 2 - s2.0 - 84863219731 22684254 113 gao w .
- l. liu m. yang y. the imprinted h19 gene regulates human placental trophoblast cell proliferation via encoding mir - 675 that targets nodal modulator 1 ( nomo1 ) rna biology 2012 9 7 1002 1010 10.4161 / rna.20807 2 - s2.0 - 84865291315 22832245 114 hernandez j. m. elahi a. clark c. w. mir - 675 mediates downregulation of twist1 and rb in afp - secreting hepatocellular carcinoma annals of surgical oncology 2013 20 supplement 3 s625 s635 10.1245 / s10434 - 013 - 3106 - 3 2 - s2.0 - 84892815362 23864307 115 liang w. fu w. wong c. the lncrna h19 promotes epithelial to mesenchymal transition by functioning as mirna sponges in colorectal cancer oncotarget 2015 6 26 22513 22525 10.18632 / oncotarget.4154 26068968 116 li y. vandenboom t. g. ii kong d. up - regulation of mir - 200 and let - 7 by natural agents leads to the reversal of epithelial - to - mesenchymal transition in gemcitabine - resistant pancreatic cancer cells cancer research 2009 69 16 6704 6712 10.1158 / 0008 - 5472.can - 09 - 1298 2 - s2.0 - 69249096109 19654291 117 guo l. chen c. shi m .
stat3 - coordinated lin - 28 - let - 7 - hmga2 and mir - 200 - zeb1 circuits initiate and maintain oncostatin m - driven epithelial - mesenchymal transition oncogene 2013 32 45 5272 5282 10.1038 / onc.2012.573 2 - s2.0 - 84881303278 23318420 118 shi x. sun m. liu h. yao y. song y. long non - coding rnas : a new frontier in the study of human diseases cancer letters 2013 339 2 159 166 10.1016 / j.canlet.2013.06.013 2 - s2.0 - 84883755139 23791884 119 fan y. shen b. tan m. tgf - beta - induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12 clinical cancer research 2014 20 6 1531 1541 10.1158 / 1078 - 0432.ccr - 13 - 1455 2 - s2.0 - 84896505509 24449823 120 hirata h. hinoda y. shahryari v. long noncoding rna malat1 promotes aggressive renal cell carcinoma through ezh2 and interacts with mir - 205 cancer research 2015 75 7 1322 1331 10.1158 / 0008 - 5472.can - 14 - 2931 25600645 121 ono h. motoi n. nagano h. long noncoding rna hotair is relevant to cellular proliferation , invasiveness , and clinical relapse in small - cell lung cancer cancer medicine 2014 3 3 632 642 10.1002 / cam4.220 24591352 122 wu y. zhang l. wang y. long noncoding rna hotair involvement in cancer tumor biology 2014 35 10 9531 9538 10.1007 / s13277 - 014 - 2523 - 7 2 - s2.0 - 84921029014 25168368 123 liu y. w. sun m. xia r. linchotair epigenetically silences mir34a by binding to prc2 to promote the epithelial - to - mesenchymal transition in human gastric cancer cell death & disease 2015 6 7 e1802 10.1038 / cddis.2015.150 124 chiyomaru t. fukuhara s. saini s. long non - coding rna hotair is targeted and regulated by mir - 141 in human cancer cells the journal of biological chemistry 2014 289 18 12550 12565 10.1074 / jbc.m113.488593 2 - s2.0 - 84899754537 24616104 125 calin g. a. croce c. m. microrna signatures in human cancers nature reviews cancer 2006 6 11 857 866 10.1038 / nrc1997 2 - s2.0 - 33750370444 17060945 126 lu j. getz g. miska e. a. microrna expression profiles classify human cancers nature 2005 435 7043 834 838 10.1038 / nature03702 2 - s2.0 - 20444460289 15944708 127 roldo c. missiaglia e. hagan j. p. microrna expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior journal of clinical oncology 2006 24 29 4677 4684 10.1200 / jco.2005.05.5194 2 - s2.0 - 33750600178 16966691 128 lin c. w. kao s. h. yang p. c. the mirnas and epithelial - mesenchymal transition in cancers current pharmaceutical design 2014 20 33 5309 5318 10.2174 / 1381612820666140128204508 24479807 129 park s .
- m. gaur a. b. lengyel e. peter m. e. the mir - 200 family determines the epithelial phenotype of cancer cells by targeting the e - cadherin repressors zeb1 and zeb2 genes & development 2008 22 7 894 907 10.1101 / gad.1640608 2 - s2.0 - 41649091906 18381893 130 korpal m. lee e. s. hu g. kang y. the mir - 200 family inhibits epithelial - mesenchymal transition and cancer cell migration by direct targeting of e - cadherin transcriptional repressors zeb1 and zeb2 the journal of biological chemistry 2008 283 22 14910 14914 10.1074 / jbc.c800074200 2 - s2.0 - 47249091921 18411277 131 yang y. ahn y .
- h. gibbons d. l. the notch ligand jagged2 promotes lung adenocarcinoma metastasis through a mir - 200 - dependent pathway in mice the journal of clinical investigation 2011 121 4 1373 1385 10.1172 / jci42579 2 - s2.0 - 79953329774 21403400 132 gill b. j. gibbons d. l. roudsari l. c. a synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and emt in a lung adenocarcinoma model cancer research 2012 72 22 6013 6023 10.1158 / 0008 - 5472.can - 12 - 0895 2 - s2.0 - 84869219078 22952217 133 gregory p. a. bracken c. p. smith e. an autocrine tgf - beta / zeb / mir - 200 signaling network regulates establishment and maintenance of epithelial - mesenchymal transition molecular biology of the cell 2011 22 10 1686 1698 10.1091 / mbc.e11 - 02 - 0103 2 - s2.0 - 79955954699 21411626 134 hahn s. jackstadt r. siemens h. hunten s. hermeking h. snail and mir - 34a feed - forward regulation of znf281 / zbp99 promotes epithelial - mesenchymal transition the embo journal 2013 32 23 3079 3095 10.1038 / emboj.2013.236 2 - s2.0 - 84888875112 24185900 135 moes m. le bechec a. crespo i. a novel network integrating a mirna - 203 / snai1 feedback loop which regulates epithelial to mesenchymal transition plos one 2012 7 4 e35440 10.1371 / journal.pone.0035440 2 - s2.0 - 84859720222 136 ding x. park s. i. mccauley l. k. wang c .
- y. signaling between transforming growth factor beta ( tgf - beta ) and transcription factor snai2 represses expression of microrna mir - 203 to promote epithelial - mesenchymal transition and tumor metastasis the journal of biological chemistry 2013 288 15 10241 10253 10.1074 / jbc.m112.443655 2 - s2.0 - 84876276472 23447531 137 zhang z. zhang b. li w. epigenetic silencing of mir - 203 upregulates snai2 and contributes to the invasiveness of malignant breast cancer cells genes & cancer 2011 2 8 782 791 10.1177 / 1947601911429743 22393463 138 kim n. h. kim h. s. kim n .
- g .
p53 and microrna - 34 are suppressors of canonical wnt signaling science signaling 2011 4 197 p .
ra71 10.1126 / scisignal.2001744 2 - s2.0 - 80455137130 139 choi y. j. lin c .
- p. ho j. j. mir - 34 mirnas provide a barrier for somatic cell reprogramming nature cell biology 2011 13 11 1353 1360 10.1038 / ncb2366 2 - s2.0 - 80455149978 22020437 140 hwang c .
- i. matoso a. corney d. c. wild - type p53 controls cell motility and invasion by dual regulation of met expression proceedings of the national academy of sciences of the united states of america 2011 108 34 14240 14245 10.1073 / pnas.1017536108 2 - s2.0 - 80052183233 21831840 141 sun y. wu j. wu s .
- h. expression profile of micrornas in c - myc induced mouse mammary tumors breast cancer research and treatment 2009 118 1 185 196 10.1007 / s10549 - 008 - 0171 - 6 2 - s2.0 - 70349941429 18777135 142 higashi t. hayashi h. ishimoto t. mir - 9 - 3p plays a tumour - suppressor role by targeting taz ( wwtr1 ) in hepatocellular carcinoma cells british journal of cancer 2015 113 2 252 258 10.1038 / bjc.2015.170 26125451 143 mori m. triboulet r. mohseni m. hippo signaling regulates microprocessor and links cell - density - dependent mirna biogenesis to cancer cell 2014 156 5 893 906 10.1016 / j.cell.2013.12.043 2 - s2.0 - 84896847445 24581491 144 zell s. schmitt r. witting s. kreipe h. h. hussein k. becker j. u. hypoxia induces mesenchymal gene expression in renal tubular epithelial cells : an in vitro model of kidney transplant fibrosis nephron extra 2013 3 1 50 58 10.1159 / 000351046 23898346 145 white k. loscalzo j. chan s. y. holding our breath : the emerging and anticipated roles of microrna in pulmonary hypertension pulmonary circulation 2012 2 3 278 290 10.4103 / 2045 - 8932.101395 23130098 146 du r. sun w. xia l. hypoxia - induced down - regulation of microrna - 34a promotes emt by targeting the notch signaling pathway in tubular epithelial cells plos one 2012 7 2 e30771 10.1371 / journal.pone.0030771 2 - s2.0 - 84857147817 147 mercer t. r. dinger m. e. mattick j. s. long non - coding rnas : insights into functions nature reviews genetics 2009 10 3 155 159 10.1038 / nrg2521 2 - s2.0 - 60349120914 148 carninci p. kasukawa t. katayama s. the transcriptional landscape of the mammalian genome science 2005 309 5740 1559 1563 10.1126 / science.1112014 16141072 149 kapranov p. willingham a. t. gingeras t. r. genome - wide transcription and the implications for genomic organization nature reviews genetics 2007 8 6 413 423 10.1038 / nrg2083 2 - s2.0 - 34249088350 150 grote p. herrmann b. g. long noncoding rnas in organogenesis : making the difference trends in genetics 2015 31 6 329 335 10.1016 / j.tig.2015.02.002 25743487 151 dey b. k. mueller a. c. dutta a. long non - coding rnas as emerging regulators of differentiation , development , and disease transcription 2014 5 4 e944014 10.4161 / 21541272.2014.944014 2 - s2.0 - 84922232458 152 li c. h. chen y. targeting long non - coding rnas in cancers : progress and prospects the international journal of biochemistry & cell biology 2013 45 8 1895 1910 10.1016 / j.biocel.2013.05.030 2 - s2.0 - 84879810589 23748105 153 wapinski o. chang h. y. long noncoding rnas and human disease trends in cell biology 2011 21 6 354 361 10.1016 / j.tcb.2011.04.001 2 - s2.0 - 79957840356 21550244 154 derrien t. guigo r. long non - coding rnas with enhancerlike function in human cells medecine / sciences 2011 27 4 359 361 10.1051 / medsci / 2011274009 2 - s2.0 - 79955608528 155 rugg - gunn p. j. ferguson - smith a. c. pedersen r. a. epigenetic status of human embryonic stem cells nature genetics 2005 37 6 585 587 10.1038 / ng1556 2 - s2.0 - 20044373656 15864307 156 sasaki h. ishihara k. kato r. mechanisms of igf2 / h19 imprinting : dna methylation , chromatin and long - distance gene regulation the journal of biochemistry 2000 127 5 711 715 10.1093 / oxfordjournals.jbchem.a022661 2 - s2.0 - 0034114584 10788777 157 jinno y. ikeda y. yun k. establishment of functional imprinting of the h19 gene in human developing placentae nature genetics 1995 10 3 318 324 10.1038 / ng0795 - 318 2 - s2.0 - 0029043178 7670470 158 casola s. pedone p. v. cavazzana a. o. expression and parental imprinting of the h19 gene in human rhabdomyosarcoma oncogene 1997 14 1503 1510 9136994 159 li x. kogner p. sandstedt b. haas o. a. ekstrom t. j. promoter - specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma international journal of cancer 1998 75 2 176 180 10.1002 /( sici ) 1097 - 0215 ( 19980119 ) 75:2 < 176 : : aid - ijc2 > 3.0.co ; 2 - r 2 - s2.0 - 0032545688 9462704 160 nakagawa h. chadwick r. b. peltomaki p. plass c. nakamura y. de la chapelle a. loss of imprinting of the insulin - like growth factor ii gene occurs by biallelic methylation in a core region of h19 - associated ctcf - binding sites in colorectal cancer proceedings of the national academy of sciences of the united states of america 2001 98 2 591 596 10.1073 / pnas.011528698 2 - s2.0 - 0035895208 11120891 161 zambrano p. segura - pacheco b. perez - cardenas e. a phase i study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes bmc cancer 2005 5 , article 44 10.1186 / 1471 - 2407 - 5 - 44 2 - s2.0 - 26844499872 162 prawitt d. enklaar t. gartner - rupprecht b. microdeletion of target sites for insulator protein ctcf in a chromosome 11p15 imprinting center in beckwith - wiedemann syndrome and wilms' tumor proceedings of the national academy of sciences of the united states of america 2005 102 11 4085 4090 10.1073 / pnas.0500037102 2 - s2.0 - 20144363310 15743916 163 dey b. k. pfeifer k. dutta a. the h19 long noncoding rna gives rise to micrornas mir - 675 - 3p and mir - 675 - 5p to promote skeletal muscle differentiation and regeneration genes and development 2014 28 5 491 501 10.1101 / gad.234419.113 2 - s2.0 - 84896812260 24532688 164 ochiai h. okada s. saito a. inhibition of insulin - like growth factor - 1 ( igf - 1 ) expression by prolonged transforming growth factor - beta1 ( tgf - beta1 ) administration suppresses osteoblast differentiation the journal of biological chemistry 2012 287 27 22654 22661 10.1074 / jbc.m111.279091 2 - s2.0 - 84863303408 22573330 165 huang y. zheng y. jia l. li w. long noncoding rna h19 promotes osteoblast differentiation via tgf - beta1 / smad3 / hdac signaling pathway by deriving mir - 675 stem cells 2015 33 12 3481 3492 10.1002 / stem.2225 26417995 166 li h. yu b. li j. overexpression of lncrna h19 enhances carcinogenesis and metastasis of gastric cancer oncotarget 2014 5 8 2318 2329 10.18632 / oncotarget.1913 2 - s2.0 - 84899552234 24810858 167 kallen a. n. zhou x .
- b. xu j. the imprinted h19 lncrna antagonizes let - 7 micrornas molecular cell 2013 52 1 101 112 10.1016 / j.molcel.2013.08.027 2 - s2.0 - 84885374473 24055342 168 gupta r. a. shah n. wang k. c. long non - coding rna hotair reprograms chromatin state to promote cancer metastasis nature 2010 464 7291 1071 1076 10.1038 / nature08975 2 - s2.0 - 77951118936 20393566 169 kogo r. shimamura t. mimori k. long noncoding rna hotair regulates polycomb - dependent chromatin modification and is associated with poor prognosis in colorectal cancers cancer research 2011 71 20 6320 6326 10.1158 / 0008 - 5472.can - 11 - 1021 21862635 170 alves c. p. fonseca a. s. muys b. r. brief report : the lincrna hotair is required for epithelial - to - mesenchymal transition and stemness maintenance of cancer cell lines stem cells 2013 31 12 2827 2832 10.1002 / stem.1547 2 - s2.0 - 84890478464 24022994 figure 1 the reciprocally regulatory feedback loop between mirnas and emt - tfs that are involved in emt .
mirnas form regulatory networks with emt - tfs and emt - associated signaling pathways that individually or cooperatively modulate emt .
emt - suppressing mirnas , such as the mir - 200 family , mir - 1 , mir - 203 , and the mir - 34 family ( in blue ) , reciprocally suppress emt - tfs ( zeb1 / 2 , snail / slug , and twist ) and consequently downregulate the expression of epithelial markers ( e - cadherin , occludin , zo - 1 , and claudins ) .
this negative feedback loop can be broken by tgf - beta or il - 6 / stat3 signaling , and p53 .
figure 2 the reciprocally regulatory feedback loop between lncrnas and emt - tfs that are involved in emt .
lncrnas form regulatory networks with emt - tfs and emt - associated signaling pathways that individually or cooperatively modulate emt .
the emt - suppressive lncrnas , h19 and meg3 , can downregulate tgf - beta signaling .
h19 , lncrna - atb , and zeb - as1 promote emt - tfs through direct or indirect regulation .
in addition , h19 is reported to possess a controversial ability to downregulate twist though its intergenic mirna , mir - 675 .
tgf - beta and il - 6 / stat3 signaling pathways also promote activity of the lncrnas , hotair , lnctcf7 , and malat1 , and thus crosstalk with notch signaling and wnt signaling , to modulate emt process .
dysregulation of these mirnas and lncrnas may lead to tumor progression .
figure 3 the molecular network composed of mirnas / lncrnas and emt - tfs .
mirnas and lncrnas form regulatory networks with emt - tfs and emt - associated signaling pathways that individually or cooperatively modulate emt .
emt - suppressing mirnas reciprocally suppress emt - tfs and consequently downregulate the expression of epithelial markers .
this negative feedback loop can be broken by tgf - beta or il - 6 / stat3 signaling , p53 , and lncrnas ( e.g. , h19 , lncrna - atb , and zeb - as1 ) .
dysregulation of these mirnas and lncrnas may lead to tumor progression .
table 1 mirnas and other molecules involved in emt .
mirna expression levels in cancer upstream regulator known targets references mir - 200 family breast cancer ; prostate cancer zeb1 / 2 , mir - 22 , slug , gata3 , tgf - beta , foxf2 zeb1 / 2 , slug , gata3 , maml2 / 3 , foxf2 [ 69 - 72 ] mir - 1 breast cancer ; prostate cancer zeb1 / 2 , mir - 22 , slug , gata3 , tgf - beta zeb1 / 2 , slug , gata3 , maml2 / 3 [ 69 - 72 ] mir - 203 breast cancer , pancreatic cancer slug , snail , tgf - beta bmi - 1 , snail , zeb1 / 2 [ 73 , 74 ] mir - 34 family pancreatic stem cell , neuroblastoma p53 , epigenetic regulation snail , zeb1 [ 75 - 77 ] mir - 9 breast cancer c - myc e - cadherin , lifr [ 78 , 79 ] mir - 135b colon cancer , nsclc , hnscc epigenetic regulation , nf - kappab , hypoxia apc , lats2 , beta - trcp , ndr2 , mob1b [ 80 - 82 ] mir - 210 breast cancer hypoxia e2f3 , hoxa1 , fgflr1 , efna3 , ptp1b , vmp1 [ 83 - 85 ] mir - 103 / 107 crc , breast cancer hypoxia dapk , klf4 , dicer [ 78 , 86 ] mir - 10b breast cancer twist hoxd - 10 [ 87 ] mir - 21 nsclc , crc , breast cancer tgf - beta / bmp , her2 / neu , hypoxia pdcd4 , tgfbr2 , pten , tap63 [ 88 - 92 ] mir - 205 breast cancer deltanp63alpha zeb1 / 2 , jagged1 [ 69 , 93 , 94 ] mir - 23b colon cancer ; bladder cancer n / a src , zeb1 [ 95 - 97 ] mir - 138 ovarian cancer ; hnscc n / a sox4 , hif - 1alpha , vimentin [ 98 - 100 ] mir - 7 gastric cancer ; breast cancer wisp igf1r , snail , setdb1 [ 27 , 101 , 102 ] hnscc : head and neck squamous cell carcinoma ; nsclc : non - small - cell lung carcinoma ; crc : colorectal cancer ; zeb1 / 2 : zinc - finger e - box binding homeobox 1 / 2 ; lifr : leukemia inhibitory factor receptor alpha ; apc : adenomatous polyposis coli ; lats2 : large tumor - suppressor kinase 2 ; beta - trcp : beta - transducin repeat - containing protein ; ndr2 : nuclear - dbf2 - related 2 ; mob1b : mps one binder 1b ; e2f3 : e2f transcription factor 3 ; hoxa1 : homeobox a1 ; fgflr1 : fibroblast growth factor receptor like - 1 ; efna3 : ephrin - a3 ; ptp1b : protein - tyrosine phosphatase 1b ; vmp1 : vacuole membrane protein 1 ; dapk : death - associated protein kinase ; klf4 : kruppel - like factor 4 ; hoxd10 : homeobox d10 ; pdcd4 : programmed cell death protein 4 ; tgfbr2 : tgf beta receptor 2 ; pten : phosphatase and tensin homolog ; wisp : wnt1 - inducible signaling pathway protein 2 ; igf1r : insulin - like growth factor 1 receptor ; setdb1 : set domain , bifurcated 1 ; n / a : not available .
table 2 lncrnas and emt .
lncrnas expression levels in cancer upstream regulator targets references zeb1 - as1 hcc n / a zeb1 ^ [ 103 ] lncrna - atb hcc tgf - beta zeb1 / 2 ^ , il - 11 ^ , mir - 200v [ 104 ] lncrna - hit breast cancer tgf - beta e - cadherinv [ 105 ] meg3 hcc tgfbr1 ^ , tgfb2 ^ , smad2 ^ [ 106 ] lncrna - hh breast cancer twist gas1 ^ [ 107 ] lnctcf7 liver cancer il - 6 tcf ^ ( wnt signaling ) [ 108 , 109 ] trerna breast cancer e - cadherinv [ 110 ] h19 n / a ctcf igf1rv , nomo1v , twistv , tgf - beta1 / smadv , mir - 138v , mir - 200v , let - 7v , [ 111 - 117 ] malat1 lung cancer , breast cancer , liver cancer , prostate cancer , renal cell carcinoma tgf - beta1 , ezh2 ^ mir - 205v [ 118 - 120 ] hotair n / a tgf - beta1 , mir - 141 mir - 34v , mir - 141v,mir - 7 [ 27 , 121 - 124 ] hcc : hepatocellular carcinoma ; tgfbr1 : transforming growth factor beta receptor 1 ; tgfb2 : transforming growth factor beta 2 ; gas1 : growth arrest - specific 1 ; tcf : transcription factor ; ctcf : ccctc - binding factor ; igf1r : insulin - like growth factor 1 receptor ; nomo1 : nodal modulator 1 ; n / a : not available .